(2S,3R,4S,6R)-4-amino-6-[5-(6,11-dimethylindolo[2,3-b]quinolin-2-yl)oxypentoxy]-2-methyloxan-3-ol
Compound with spectra: 1 NMR
![(2S,3R,4S,6R)-4-amino-6-[5-(6,11-dimethylindolo[2,3-b]quinolin-2-yl)oxypentoxy]-2-methyloxan-3-ol](/api/compound/2KKZsk7i9Lw.png?ph=true&h=300&w=458 "(2S,3R,4S,6R)-4-amino-6-[5-(6,11-dimethylindolo[2,3-b]quinolin-2-yl)oxypentoxy]-2-methyloxan-3-ol")
| SpectraBase Compound ID | 2KKZsk7i9Lw |
|---|---|
| InChI | InChI=1S/C28H35N3O4/c1-17-21-15-19(33-13-7-4-8-14-34-25-16-22(29)27(32)18(2)35-25)11-12-23(21)30-28-26(17)20-9-5-6-10-24(20)31(28)3/h5-6,9-12,15,18,22,25,27,32H,4,7-8,13-14,16,29H2,1-3H3/t18-,22-,25+,27-/m0/s1 |
| InChIKey | MAGKQEPXQACUGN-CDQLRIBDSA-N |
| Mol Weight | 477.6 g/mol |
| Molecular Formula | C28H35N3O4 |
| Exact Mass | 477.262757 g/mol |
| Enantiomer InChIKey | MAGKQEPXQACUGN-DRPYMNLWSA-N |
| Copyright | Copyright © 2016-2025 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
(2S,3S,4S,6R)-4-amino-6-[2-(6,11-dimethylindolo[2,3-b]quinolin-2-yl)oxyethoxy]-2-methyloxan-3-ol
2-METHOXY-6,9,11-TRIMETHYL-6H-INDOLO-[2,3-B]-QUINOLINE
2,9-DIMETHOXY-6,11-DIMETHYL-6H-INDOLO-[2,3-B]-QUINOLINE
(2S,3R,4S,6R)-4-amino-6-[5-(6,11-dimethylindolo[2,3-b]quinolin-9-yl)oxypentoxy]-2-methyloxan-3-ol
(2S,3S,4S,6R)-4-amino-6-[5-(6,11-dimethylindolo[2,3-b]quinolin-9-yl)oxypentoxy]-2-methyloxan-3-ol
9-METHOXY-2,6,11-TRIMETHYL-6H-INDOLO-[2,3-B]-QUINOLINE
NDVZSXMQDRTYNQ-UHFFFAOYSA-N
YASQEOMHVCKMIG-UHFFFAOYSA-N
TRIPTONOTERPENE-METHYLETHER;3,4,4A,9,10,10A-HEXAHYDRO-6-HYDROXY-1,1,4A-TRIMETHYL-7-(1-METHYLETHYL)-8-METHOXY-2(1H)-PHENANTHREN-2-ONE
| Title | Journal or Book | Year |
|---|---|---|
| 1H and13C NMR data for indolo[2,3-b]quinoline–aminoglycoside hybrids, a novel potent anticancer drug family | Magnetic Resonance in Chemistry | 2006 |